J K Björk et al. demonstrated that HSF2 is a suppressor of prostate cancer invasion [48], but another study demonstrated that HSF2 was increased in lung cancer and associated with the occurrence of lung cancer by enhancing the expression of HSPs [49]. The gene discussed is HSF2; the disease is prostate carcinoma.